Smarter. Stronger. Together. Expert Guidance, Tools, and Resources to Optimize the Care of Patients With HER2-Negative Early-Stage Breast Cancer

Get up to date on the multidisciplinary care of patients with HER2-negative early-stage breast cancer with this comprehensive educational program featuring Medical Minute modules, downloadable slides, topical commentaries, a patient resource, and an interactive decision support tool providing case-specific treatment recommendations from an expert panel.

Share

Program Content

Activities

Dilemmas in HER2neg EBC
Clinical Dilemmas When Selecting Adjuvant Therapy for HER2-Negative Early-Stage Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 19, 2024

Expires: July 18, 2025

Challenges for HER2neg EBC
Current Challenges With Individualizing Therapy for HER2-Negative Early-Stage Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 03, 2024

Expires: April 02, 2025

Activities

Adjuvant CDK Inhibitors for EBC
Integrating Adjuvant CDK4/6 Inhibitors Into Care of Patients With HR-Positive/HER2-Negative Early-Stage Breast Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 01, 2024

Expires: April 30, 2025

BRCA Testing and Targeting in EBC
Germline BRCA Testing and Targeting in HER2-Negative Early-Stage Breast Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2024

Expires: May 06, 2025

ICIs for EBC
Immune Checkpoint Inhibitor Therapy for HER2-Negative Early-Stage Breast Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 13, 2024

Expires: May 12, 2025

Activities

Adjuvant CDK Inhibitors for EBC Slides
Integrating Adjuvant CDK4/6 Inhibitors Into Care of Patients With HR-Positive/HER2-Negative Early-Stage Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 01, 2024

Expires: April 30, 2025

BRCA Testing and Targeting in EBC Slides
Germline BRCA Testing and Targeting in HER2-Negative Early-Stage Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2024

Expires: May 06, 2025

ICIs for EBC Slides
Immune Checkpoint Inhibitor Therapy for HER2-Negative Early-Stage Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 16, 2024

Expires: May 15, 2025

Activities

Adjuvant Tx HER2 Negative EBC
Adjuvant Therapy for HER2-Negative Early Breast Cancer: Interactive Decision Support Tool
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: August 22, 2024

Expires: August 21, 2025

Activities

HER2neg EBC Patient Resource
Oral Treatments for HER2-Negative Early-Stage Breast Cancer: A Guide for Patients and Caregivers
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2024

Expires: June 04, 2025

Patient Resource Treatment for HER2 Negative EBC
Patient Resource: Postsurgery Treatment Options for HER2-Negative Early-Stage Breast Cancer
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: September 19, 2024

Expires: September 18, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Breastcancer.org

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner